GI & Endoscopy

Southlake-based Texas Digestive Disease Consultants retained investment banking firm Nexus Health Capital, according to PE Hub.  

Here are five hospitals and practices with gastroenterology services making news:

The FDA and Pentax announced a voluntary recall of all ED-3490TK video duodenoscopes to replace a series of parts and update the operations manual, Medscape reports.

Akron (Ohio) Digestive Disease Consultants partner and American College of Gastroenterology Board of Governors Chair Costas Kefalas, MD, shared his thoughts with Becker's ASC Review on the challenges of increased regulation and the importance of embracing emerging technology.

Chapel Hill-based University of North Carolina professor of medicine and American Gastroenterological Association Government Affairs Committee member Lisa Gangarosa, MD, spoke on the importance of continuing education and staying engaged through advocacy.

Motus GI will sell 4.25 million shares of its common stock at $6 per share as it attempts to raise $25.5 million through a U.S.-based initial public offering, Seeking Alpha reports.

Theravance Biopharma Ireland and Janssen Biotech entered into a co-development and commercialization agreement over TD-1473, an inflammatory intestinal disease inhibitor.

The American Society for Metabolic and Bariatric Surgery added the intragastric balloon to its list of approved procedures and devices, effective Feb. 5.

A study in Inflammatory Bowel Diseases used a novel simulation model to assess the optimal treatment positioning for patients with moderately to severely active ulcerative colitis and to predict treatment response. The model supports the use of Entyvio as an…

Here are six updates on GI companies from the past week.